Breckenridge Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Acetazolamide | Acetazolamide | 2020-04-30 | ||
| Apixaban | Apixaban | 2021-07-26 | 2026-2031 | |
| Asenapine | Asenapine | 2020-12-10 | 2026-2033 | |
| Bretylium | Bretylium | 2018-12-21 | ||
| Cabazitaxel | Cabazitaxel | 2022-06-23 | 2025-2030 | |
| Carfilzomib | Carfilzomib | 2021-06-11 | 2025-2033 | |
| Clobazam | Clobazam | 2018-10-22 | 2024-2040 | |
| Duloxetine | Duloxetine | 2014-06-11 | 2037 | |
| Entecavir | Entecavir | 2018-03-15 | ||
| Epinastine | Epinastine | 2011-03-14 | ||
| Eplerenone | Eplerenone | 2018-09-14 | ||
| Estradiol norethindrone | Estradiol, Norethindrone | 2008-04-17 | 2024-2037 | |
| Everolimus | Everolimus | 2021-03-05 | 2025-2028 | |
| Exemestane | Exemestane | 2019-02-21 |
1
2
3
>
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use